The D allele of the angiotensin-converting enzyme gene contributes towards blood LDL-cholesterol levels and the presence of hypertension

Atherosclerosis

Volumn 145, Issue 2, 1999, Pages 267-271

  Oren, Ilana ^a   Brook, J Gerald ^a   Gershoni Baruch, Ruth ^a   Kepten, Ilana ^a   Tamir, Ada ^a   Linn, Shai ^a   Wolfovitz, Efrat ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Angiotensin converting enzyme; CAD risk factors; Coronary artery disease; D Allele; Deletion insertion polymorphism; Hypertension

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE DELETION; GENE INSERTION; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ALLELES; BLOOD PRESSURE; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; DNA; DNA TRANSPOSABLE ELEMENTS; GENE DELETION; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 0032786556     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00075-1     Document Type: Article

References (48)

1. Daemen MJAP, Lomearo DM, Borman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;63:450-6.
2. Powell JS, Clozel JP, Muller RK, Kuhn, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular surgery. Science 1989;245:186-8.
3. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 1991;9:17-22.
4. Peic LR, Gross GJ, Waritier DC. Mechanism of coronary vasodilation produced by bradykinin. Circulation 1991;83:2048-56.
5. Wiemer G, Schokens BA, Beoker RM, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 1991;18:558-63.
6. Fatly RD, Ho KL, Canetero OA, Scich AG. Kinins mediate the antiproliferative effect of Ramipril in rat carotid artery. Biochem Biophys Res Commun 1992;182:283-8.
7. Beohar N, Damaraju S, Prather A, Yu Q-T, Raizner A, Kleiman NS, Roberts R, Marian AJ. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med 1995;43:275-80.
8. Mattei MG, Hubert C, Alhenco-Gelas F, Roeckel N, Corvol P, Soubrier F. Angiotensin I converting enzyme gene is on chromosome 14. Cytogenet Cell Genet 1989;51:1041.
9. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. A deletion/insertion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
11. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
12. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
13. Tiret L, Kee F, Poirer O, Nicaud V, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Amouyel P, Cambien F. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993;341:991-2.
14. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P. Deletion/insertion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:3662-5.
15. Kogawa K, Nishizawa Y, Hosoi M, Kawagishi T, Maekawa K, Shoji T, Okuno Y, Morii H. Effect of polymorphism on apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness. Diabetes 1997;46:682-7.
16. Talmud PJ, Watts GF, McBride S, Mandalia S, Brunt JNH, Coltart DJ, Lewis B, Humphries SE. Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease. Atherosclerosis 1995;114:133-5.
17. Sigusch HH, Vogt S, Gruber U, Reinhardt D, Lang K, Surber R, Farker K, Muller S, Hoffmann A. Angiotensin-I-converting enzyme DD is a risk factor of coronary artery disease. Scand J Clin Lab Invest 1997;57:127-32.
18. Schunkert H, Hense H-W, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GAJ. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. New Engl J Med 1994;330:1634-8.
19. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Ferryman MB. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-5.
20. Marian AJ, Yu Q-T, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-6.
21. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. New Engl J Med 1995;332:706-11.
22. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995;112:137-43.
23. Ko YL, Ko YS, Wang SM, Chu PH, Teng MS, Cheng NJ, Chen WJ, Hsu TS, Kuo CT, Chiang CW, Lee YS. Angiotensinogen and angiotensin-I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese. Hum Genet 1997;100:210-4.
24. Winkelmann BR, Nauck M, Klein B, Russ AP, Bohm BO, Siekmeier R, Ihnken K, Verho M, Gross W, Marz W. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 1996;125:19-25.
25. Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesaniemi YA, Savolainen MJ. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996;28:1070-5.
26. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel J-M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992;1:72-5.
27. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJW, Watt GCM. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993;21:455-60.
28. Jeng JR, Harn HJ, Jeng CY, Yueh KC, Shieh SM. Angiotensin I converting enzyme gene polymorphism in Chinese patients with hypertension. Am J Hypertens 1997;10(1):558-61.
29. Chiang FT, Chern TH, Lai ZP, Tseng CD, Hsu KL, Lo HM, Tseng YZ. Age- and gender-dependent association of the angiotensin-converting enzyme gene with essential hypertension in a Chinese population. J Hum Hypertens 1996;10:823-6.
30. Jian M, Cao X, Huang J, Qi J, Liu G, Wang J, Bai D, Qiao D, Zhao JF, Feng S, Liu L. Polymorphism of angiotensin I converting enzyme gene in the older Chinese: linked to ambulatory blood pressure levels and circadian blood pressure rhythm. Int J Cardiol 1996;55:33-40.
31. Miettinen HE, Korpela K, Hamalainen L, Kontula K. Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet 1994;94:189-92.
32. Corbo RM, Vilardo T, Mantuano E, Ruggeri M, Gemma AT, Scacchi R. Apolipoprotein B and E, and angiotensin I-converting enzyme (ACE) genetic polymorphisms in Italian women with coronary artery disease (CAD) and their relationships with plasma lipid and apolipoprotein levels. Clin Genet 1997;52:77-82.
33. Watanabe Y, Ishigami T, Kawano Y, Umahara T, Nakamori A, Mizushima S, Hibi K, Kobayashi I, Tamura K, Ochiai H, Umemura S, Ishii M. Angiotensin-converting enzyme gene D/I polymorphism and carotid plaques in Japanese. Hypertension 1997;30(2):569-73.
34. Takahashi K, Nakamura H, Kubota I, Takahashi N, Tomolke H. Association of ACE gene polymorphisms with coronary artery disease in a northern area of Japan. Jpn Heart J 1995;36:557-64.
35. Saha N, Talmud PJ, Tay JS, Humphries SE, Basair J. Lack of association of angiotensin-converting enzyme (ACE). Gene deletion/insertion polymorphism with CAD in two Asian populations. Clin Genet 1996;50:121-5.
36. Katsuya T, Horiuchi M, Chen Y-DI, Koike G, Pratt R, Dzau VJ, Reaven GM. Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. Arterioscler Thromb Vasc Biol 1995;15:779-82.
37. Proudler AJ, Crook D, Godsland IF, Collins P, Rosano GMC, Stevenson JC. Serum angiotensin-I-converting enzyme activity in women with cardiological syndrome X: relation to blood pressure and lipid and carbohydrate metabolic risk markers for coronary heart disease. J Clin Endocrinol Metab 1995;80:696-9.
38. Panahloo A, Andres C, Mohamed-Ali V, Gould MM, Talmud P, Humphries SE, Yudkin JS. The insertion allele of the ACE gene D/I polymorphism. A candidate gene for insulin resistance? Circulation 1995;92:3390-3.
39. Sertic J, Hebrang D, Janus D, Salzer B, Niksic M, Cvoriscec D, Stavljenic-Rukavina A. Association between deletion polymorphism of the angiotensin-converting enzyme gene and cerebral atherosclerosis. Eur J Clin Chem Clin Biochem 1996;34:301-4.
40. Barley J, Blackwood A, Miller M, Markandu ND, Carter ND, Jeffery S, Cappuccio FP, MacGregor GA, Sagnella GA. Angiotensin converting enzyme gene D/I polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens 1996;10:31-5.
41. Mastana S, Nunn J. Angiotensin-converting enzyme deletion polymorphism is associated with hypertension in a Sikh population. Hum Hered 1997;47:250-3.
42. Chuang LM, Chiu KC, Chiang FT, Lee KC, Wu HP, Lin BJ, Tai TY. Deletion/insertion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolism 1997;46:1211-4.
43. Jeng JR, Shieh SM, Harn HJ, Lee MM, Sheu WH, Jeng CY. Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with hypertension. J Hypertens 1997;15:963-8.
44. Hauf-Zachariou U, Widmann L, Zulsdorf B, Hennig M, Lang PD. A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia. Eur J Clin Pharmacol 1993;45:95-100.
45. Catalano M, Cislaghi C, Carzaniga G, Aronica A, Seregni R, Libretti A. Effects of treatment with verapamil SR and captopril on the lipid profile of hypertensive patients. Drugs 1992;44(Suppl 1):88-93.
46. Grimm RH Jr, Flack JM, Grandits GA, Elmer PJ, Neaton JD, Cutler JA, Lewis C, McDonald R, Schoenberger J, Stamler J. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. J Am Med Assoc 1996;275:1549-56.
47. Costa FV, Borghi C, Mussi A, Ambrosioni E. Hypolipidemic effects of long-term antihypertensive treatment with captopril. A prospective study. Am J Med 1988;84:159-61.
48. Perani G, Muggia C, Martignoni A, Bongarzoni A, Radaelli A, Testa F, Finardi G. Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril. Clin Ther 1987;9:635-9.